Literature DB >> 19008233

Modulation of cell motility by spatial repositioning of enzymatic ATP/ADP exchange capacity.

Remco van Horssen1, Edwin Janssen, Wilma Peters, Loes van de Pasch, Mariska M Te Lindert, Michiel M T van Dommelen, Peter C Linssen, Timo L M Ten Hagen, Jack A M Fransen, Bé Wieringa.   

Abstract

ATP is the "principal energy currency" in metabolism and the most versatile small molecular regulator of cellular activities. Although already much is known about the role of ATP in fundamental processes of living systems, data about its compartmentalization are rather scarce, and we still have only very limited understanding of whether patterns in the distribution of intracellular ATP concentration ("ATP inhomogeneity") do exist and have a regulatory role. Here we report on the analysis of coupling of local ATP supply to regulation of actomyosin behavior, a widespread and dynamic process with conspicuous high ATP dependence, which is central to cell shape changes and cell motility. As an experimental model, we use embryonic fibroblasts from knock-out mice without major ATP-ADP exchange enzymes, in which we (re)introduce the ATP/ADP exchange enzyme adenylate kinase-1 (AK1) and deliberately manipulate its spatial positioning by coupling to different artificial location tags. By transfection-complementation of AK1 variants and comparison with yellow fluorescent protein controls, we found that motility and spreading were enhanced in cells with AK1 with a focal contact guidance tag. Intermediary enhancement was observed in cells with membrane-targeted or cytosolic AK1. Use of a heterodimer-inducing approach for transient translocation of AK1 to focal contacts under conditions of constant global AK1 activity in the cell corroborated these results. Based on our findings with these model systems, we propose that local ATP supply in the cell periphery and "on site" fuelling of the actomyosin machinery, when maintained via enzymes involved in phosphoryl transfer, are codetermining factors in the control of cell motility.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19008233     DOI: 10.1074/jbc.M806974200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

Review 1.  Dysregulated pH: a perfect storm for cancer progression.

Authors:  Bradley A Webb; Michael Chimenti; Matthew P Jacobson; Diane L Barber
Journal:  Nat Rev Cancer       Date:  2011-08-11       Impact factor: 60.716

2.  A ring barrier-based migration assay to assess cell migration in vitro.

Authors:  Asha M Das; Alexander M M Eggermont; Timo L M ten Hagen
Journal:  Nat Protoc       Date:  2015-05-21       Impact factor: 13.491

3.  New crystal structures of adenylate kinase from Streptococcus pneumoniae D39 in two conformations.

Authors:  Trung Thanh Thach; Sangho Lee
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2014-10-25       Impact factor: 1.056

4.  Slowing down the Grand Touring Prototype speed of cancer cells.

Authors:  Anna Bianchi-Smiraglia; Mikhail A Nikiforov
Journal:  Mol Cell Oncol       Date:  2015-06-10

Review 5.  Adenylate kinase and AMP signaling networks: metabolic monitoring, signal communication and body energy sensing.

Authors:  Petras Dzeja; Andre Terzic
Journal:  Int J Mol Sci       Date:  2009-04-17       Impact factor: 6.208

6.  ATP changes the fluorescence lifetime of cyan fluorescent protein via an interaction with His148.

Authors:  Jan Willem Borst; Marieke Willemse; Rik Slijkhuis; Gerard van der Krogt; Sergey P Laptenok; Kees Jalink; Be Wieringa; Jack A M Fransen
Journal:  PLoS One       Date:  2010-11-05       Impact factor: 3.240

7.  Intracellular NAD(H) levels control motility and invasion of glioma cells.

Authors:  Remco van Horssen; Marieke Willemse; Anna Haeger; Francesca Attanasio; Tuba Güneri; Albrecht Schwab; Christian M Stock; Roberto Buccione; Jack A M Fransen; Bé Wieringa
Journal:  Cell Mol Life Sci       Date:  2013-01-10       Impact factor: 9.261

Review 8.  Adenylate Kinase: A Ubiquitous Enzyme Correlated with Medical Conditions.

Authors:  Mihaela Ileana Ionescu
Journal:  Protein J       Date:  2019-04       Impact factor: 2.371

9.  A purine nucleotide biosynthesis enzyme guanosine monophosphate reductase is a suppressor of melanoma invasion.

Authors:  Joseph A Wawrzyniak; Anna Bianchi-Smiraglia; Wiam Bshara; Sudha Mannava; Jeff Ackroyd; Archis Bagati; Angela R Omilian; Michael Im; Natalia Fedtsova; Jeffrey C Miecznikowski; Kalyana C Moparthy; Shoshanna N Zucker; Qianqian Zhu; Nadezhda I Kozlova; Albert E Berman; Keith S Hoek; Andrei V Gudkov; Donna S Shewach; Carl D Morrison; Mikhail A Nikiforov
Journal:  Cell Rep       Date:  2013-10-17       Impact factor: 9.423

10.  Increased OXPHOS activity precedes rise in glycolytic rate in H-RasV12/E1A transformed fibroblasts that develop a Warburg phenotype.

Authors:  Ad J C de Groof; Mariska M te Lindert; Michiel M T van Dommelen; Min Wu; Marieke Willemse; Amy L Smift; Mike Winer; Frank Oerlemans; Helma Pluk; Jack A M Fransen; Bé Wieringa
Journal:  Mol Cancer       Date:  2009-07-31       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.